Jove
Visualize
联系我们

相关概念视频

Drug Discovery: Overview01:26

Drug Discovery: Overview

7.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Tandem electrostatic lens as a zoom system to achieve ultra-high magnification in microscope imaging mass spectrometry.

The Review of scientific instruments·2025
Same author

Excitable Ras dynamics-based screens reveal RasGEFX is required for macropinocytosis and random cell migration.

Nature communications·2025
Same author

A dynamic partitioning mechanism polarizes membrane protein distribution.

Nature communications·2023
Same author

A dynamic partitioning mechanism polarizes membrane protein distribution.

bioRxiv : the preprint server for biology·2023
Same author

Field model for multistate lateral diffusion of various transmembrane proteins observed in living Dictyostelium cells.

Journal of cell science·2023
Same author

Heterotrimeric Gq proteins act as a switch for GRK5/6 selectivity underlying β-arrestin transducer bias.

Nature communications·2022
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jun 10, 2025

A Rapid and Quantitative Fluorimetric Method for Protein-Targeting Small Molecule Drug Screening
08:34

A Rapid and Quantitative Fluorimetric Method for Protein-Targeting Small Molecule Drug Screening

Published on: October 16, 2015

10.0K

基于单个分子追踪的药物查.

Daisuke Watanabe1,2, Michio Hiroshima3,4, Masato Yasui5

  • 1Laboratory of Single Molecule Biology, Graduate School of Frontier Biosciences, Osaka University, Suita, Osaka, Japan.

Nature communications
|October 17, 2024
PubMed
概括
此摘要是机器生成的。

单分子追踪屏幕FDA批准的药物用于针对表皮生长因子受体 (EGFR) 的新型癌症疗法. 该方法识别了已知的抑制剂和影响EGFR流动性和药物发现的聚类的新化合物.

更多相关视频

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.6K
Single-Molecule Tracking Microscopy - A Tool for Determining the Diffusive States of Cytosolic Molecules
00:10

Single-Molecule Tracking Microscopy - A Tool for Determining the Diffusive States of Cytosolic Molecules

Published on: September 5, 2019

8.2K

相关实验视频

Last Updated: Jun 10, 2025

A Rapid and Quantitative Fluorimetric Method for Protein-Targeting Small Molecule Drug Screening
08:34

A Rapid and Quantitative Fluorimetric Method for Protein-Targeting Small Molecule Drug Screening

Published on: October 16, 2015

10.0K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.6K
Single-Molecule Tracking Microscopy - A Tool for Determining the Diffusive States of Cytosolic Molecules
00:10

Single-Molecule Tracking Microscopy - A Tool for Determining the Diffusive States of Cytosolic Molecules

Published on: September 5, 2019

8.2K

科学领域:

  • 细胞生物学 细胞生物学
  • 药理学 药理学是指药理学的学科.
  • 生物物理学的生物物理.

背景情况:

  • 单分子跟踪 (SMT) 揭示了对跨膜受体信号的洞察力,包括移动性和聚类动态.
  • 这些动态对于受体激活/非激活至关重要,并为药物发现查提供了潜在的途径.
  • 传统的选方法可能会错过针对细微受体功能的化合物.

研究的目的:

  • 证明基于SMT的查对识别针对疾病相关受体的新疗法的有用性.
  • 使用SMT选FDA批准的药物,以检测影响表皮生长因子受体 (EGFR) 信号的化合物.
  • 探索 EGFR 依赖性疾病治疗干预的以前未有针对性的机制.

主要方法:

  • 开发和应用一个自动化,高通量单分子分析系统.
  • 对1134种FDA批准的药物进行查,以检测它们对EGFR流动性和活细胞中的聚类的影响.
  • 分析药物诱导的EGFR酸化依赖的移动性转移和EGF诱导的信号的变化.

主要成果:

  • 屏检测发现了18种有效化合物,包括所有已知的EGFR向型氨酸激酶抑制剂 (TKI),这些药物改变了EGFR的移动性.
  • 发现了新的非TKI化合物,这些化合物影响了EGFR的移动性和/或独立于EGF刺激的聚类.
  • 这些非TKI化合物诱导了EGFR内部化,并阻碍了依赖EGFR的细胞生长.

结论:

  • 基于SMT的查是一种强大的方法,用于发现针对各种受体功能的治疗方法,包括传统方法错过的功能.
  • 该研究验证了SMT作为一种可行的平台,用于识别具有以前未被定位的作用机制的新药候选药物.
  • 这种方法扩大了对EGFR等受体的药物发现范围,提供了新的治疗策略.